|
|
41
|
|
|
5641RV
|
|
|
CEFTAZIDIME 1G INJ (SLS) (B)
|
|
|
CEFTAZIDIME
|
|
|
CEFTAZIDIME
|
|
|
1G VIAL
|
|
|
B
|
|
|
5.36
|
|
|
5.3551
|
|
|
1G
|
|
|
VIAL
|
|
|
28
|
|
|
VIAL
|
|
|
SLS
|
|
|
SAMARTH LIFE SCIENCES
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
15
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
08120612
|
|
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
THIRD GEN CEPHALOSPORINS
|
|
|
|